The triggering receptor expressed on myeloid cells-1 (TREM-1) is a recently discovered cell surface molecule expressed on neutrophils, mature monocytes, and macrophages \[[@B1]\]. Activation of TREM-1 synergistically enhances proinflammatory cytokine production induced by toll-like receptor (TLR) stimulation \[[@B2]\]. A soluble form of TREM-1 has shown promise as a sensitive and specific biomarker for sepsis in humans \[[@B3]-[@B5]\]. Expression and function of TREM-1 in the dog has yet to be characterized. We hypothesize that the expression of canine TREM-1 will be upregulated after stimulation with TLR agonists. We assessed TREM-1 expression on canine neutrophils after exposure to TLR agonists *in vitro*and *in vivo*after i.v. LPS administration. *In vitro*, expression of TREM-1 on neutrophils is significantly upregulated by stimulation with microbe-derived agonists against TLR2/6 (Pam2CSK4), TLR1/2 (Pam3CSK4), and TLR4/MD2 (ultrapure LPS and wildtype LPS) (paired *t*test, *P*\< 0.05). The TLR5 agonist flagellin did not significantly upregulate TREM-1 expression at any time point. See Figure [1](#F1){ref-type="fig"}. In contrast, i.v. administration of LPS to dogs resulted in a significant decrease in both TREM-1 expression and the percentage of TREM-1-positive neutrophils from 6 hours through 12 hours post LPS administration. See Figure [2](#F2){ref-type="fig"}. The disparity between *in vitro*and *in vivo*effects of LPS suggest other factors, such as systemic and local cytokine production and neutrophil turnover, may influence expression and shedding of TREM-1 on canine neutrophils. We suggest that naturally occurring sepsis in the dog represents the ideal model for defining diagnostic biomarkers and discovering efficacious therapeutics for use in human sepsis.

![**Kinetics of TREM-1 expression after TLR agonist stimulation *in vitro***.](cc9138-1){#F1}
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